Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Jan;53(1):20–27. doi: 10.1097/QAI.0b013e3181bdf68e

Table 2.

Age Specific Rates of Serious Gastroenteritis Events in the HIVNET 012 and HIVIGLOB/ NVP Trials

HIVNET 012 HIVIGLOB/NVP
Age Interval
(months)
Person Time of
Follow-up
(child-months)
Rate per 1000
child-mos
(95% CI)
Person Time of
Follow-up
(child-months)
Rate per 1000
child-mos
(95% CI)
p-value
0-1 570 0 (0 - 4.3) 666 1.5 (0.1 - 7.0) 1.00
1-2 539 1.9 (0.2 - 8.7) 642 4.7 (1.3 - 12.5) 0.76
2-3 512 3.9 (0.8 - 12.5) 627 9.6 (4.0 - 19.7) 0.44
3-4 504 0 (0 - 4.9) 617 16.2 (8.3 - 28.8) 0.005**
4-5 499 0 (0 - 4.9) 612 9.8 (4.1 - 20.2) 0.056
5-6 499 2.0 (0.2 - 9.4) 610 9.8 (4.1 - 20.3) 0.21
6-7 493 2.0 (0.2 - 9.5) 603 13.3 (6.3 - 25.0) 0.08
7-8 488 10.3 (3.9 - 22.5) 599 15.0 (7.4 - 27.4) 0.68
8-9 487 4.1 (0.8 - 13.2) 596 10.1 (4.2 - 20.8) 0.44
9-10 482 20.8 (10.7 - 36.8) 594 8.4 (3.2 - 18.5) 0.15
10-11 479 8.4 (2.8 - 19.9) 592 10.1 (4.2 - 20.9) 1.00
11-12 477 0 (0 - 5.2) 590 3.4 (0.7 - 10.9) 0.61
12-13 469 0 (0 - 5.3) 587 8.5 (3.2 - 18.7) 0.11
13-14 463 0 (0 - 5.3) 579 1.7 (0.2 - 8.1) 1.00
14-15 461 2.2 (0.2 - 10.1) 559 7.2 (2.4 - 17.0) 0.51
15-16 461 2.2 (0.2 - 10.1) 534 5.6 (1.6 - 15.0) 0.74
16-17 461 0 (0 - 5.3) 511 7.8 (2.6 - 18.6) 0.15
17-18 460 2.2 (0.2 - 10.1) 473 2.1 (0.2 - 9.9) 1.00
18-19 451 0 (0 - 5.5) 163 0 (0 - 15.1) 1.00
**

Significant at p-value of 0.05